1604530

Rivaroxaban

United States Pharmacopeia (USP) Reference Standard

• 동의어(들): (S)-Rivaroxaban, 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
• 실험식(Hill 표기법): C₁₉H₁₈ClN₃O₅S
• CAS 번호: 366789-02-8
• Molecular Weight: 435.88
• UNSPSC Code: 41116107
• NACRES: NA.24
• MDL number: MFCD11974010

속성

• grade: pharmaceutical primary standard
• agency: USP
• API family: rivaroxaban
• manufacturer/tradename: USP
• application(s): pharmaceutical; pharmaceutical; pharmaceutical (small molecule)
• format: neat
• storage temp.: 2-8°C
• SMILES string: [s]1c(ccc1C(=O)NC[C@@H]2OC(=O)N(C2)c3ccc(cc3)N4CCOCC4=O)Cl
• InChI: 1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1
• InChI key: KGFYHTZWPPHNLQ-AWEZNQCLSA-N

설명

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Rivaroxaban USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Rivaroxaban Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

안전성 정보

• 픽토그램: GHS09
• 위험 코드: H411
• 주의 사항: P273 - P391 - P501
• Hazard Classifications: Aquatic Chronic 2
• 저장 등급: 11 - Combustible Solids
• 인화점 (F): Not applicable
• 인화점 (°C): Not applicable